Brought to you by:
Start of PAD Awareness Month heralds joint national effort to prevent amputations
The PAD Pulse Alliance—a coalition of leading medical societies that includes the Society for Vascular Surgery (SVS) dedicated to improving vascular health—is urging patients, providers and policymakers to act through its Get a Pulse on PAD Campaign as national PAD…
SWEDEPAD re-opens paclitaxel safety discussion, finds drug-coated devices do not improve outcomes
Drug-coated balloons and stents were not associated with reduced risk of amputation or improved quality of life compared with uncoated devices in the SWEDEPAD 1 and 2 trials. In addition, higher five-year mortality with drug-coated devices in patients with intermittent…
Pharmacologic treatment, follow-up in cessation services help drive abstinence in PAD patients
A recent French study suggests smoking cessation in patients with peripheral arterial disease (PAD) is achievable with intensive and appropriate management, with the prescription of a pharmacologic smoking cessation treatment and follow-up with smoking cessation services both identified as important…
Celebrity-prompted awareness in vascular surgery
The vascular surgery field received a rare moment in the public spotlight recently as President Donald J. Trump was diagnosed with chronic venous insufficiency (CVI). The White House press secretary and appointed physician to the president even made statements on…
FDA grants approval for IDE study on Advance Evero 18 everolimus-coated balloon catheter
The Food and Drug Administration (FDA) has granted approval for Cook Medical to initiate an investigational device exemption (IDE) study on the Advance Evero 18 everolimus-coated percutaneous transluminal angioplasty (PTA) balloon catheter, the company reported today. The clinical study…
The benefits of a heart and vascular institute
Vikram S. Kashyap, MD, pushes back against a recent editorial from Vascular Specialist medical editor Malachi Sheahan III, MD, in which the latter called into question the value of heart and vascular centers to the vascular surgical specialty. I am…
Legacy teams lead the way in Vascular Health Step Challenge
The Society for Vascular Surgery (SVS) Foundation is placing a spotlight on its “Legacy Teams”—those who have gone the extra mile, literally!—to make the annual Vascular Health Step Challenge a success year after year. This year will see the return…
Analysis of BEST-CLI, PREVENT III reveals significant improvement in vein bypass outcomes over 20-year period
A post-hoc comparison of the BEST-CLI and PREVENT III multicenter, prospective, randomized controlled trials (RCTs) aimed at evaluating outcomes of vein bypass in chronic limb threatening ischemia (CLTI) patients over the past two decades found that they had “significantly improved”…
First patient enrolled in AngioDynamics’ AMBITION BTK trial for CLTI
AngioDynamics today announced enrollment of the first patient in AMBITION BTK, a randomized study of the Auryon atherectomy system in patients with below-the-knee chronic limb-threatening ischemia (CLTI). A press release details that AMBITION BTK is a prospective, multicenter, randomized controlled…
Complex PAD skills course registration is open
Registration is now open for the Society for Vascular Surgery (SVS) Complex Peripheral Vascular Interventions (CPVI) Skills Course, taking place from Sept. 20–21 in Rosemont, Illinois. The two-day course will provide participants with hands-on training in the latest techniques and…